You are here: Industry Insights > Insulin

News List

Novo Nordisk offers free 90-day insulin supply to patients due to COVID-19 europeanpharmaceuticalreview
April 20, 2020
Novo Nordisk has set up a programme to allow patients in the US experiencing financial hardship because of COVID-19 to receive free insulin for 90 days.
Wearable patch device could provide an affordable insulin therapy for type 2 diabetics europeanpharmaceuticalreview
April 02, 2020
A study comparing the V-Go device administering regular human insulin and rapid acting insulin analogues found they were equally effective and safe at controlling blood glucose.
Biocon’s Insulin Manufacturing Facility in Malaysia Receives EIR from US FDA expresspharma
April 01, 2020
The Inspection has been closed with a “VAI” (Voluntary Action Indicated) classification in the EIR, for the three observations issued at the conclusion of the inspection in Feb 2020.
COVID-19 update: Eli Lilly assures security of insulin supply europeanpharmaceuticalreview
March 26, 2020
Having become aware of insulin shortages in pharmacies, the company has stated that its products are not backordered and should be available for delivery by wholesalers.
Eli Lilly expects no coronavirus-related drug shortages pharmaceutical-technology
March 05, 2020
Eli Lilly has announced that the company is not expecting coronavirus-related drug shortages, including all forms of insulin.
Coffee Consumption Does Not Affect Insulin Sensitivity drugs
January 06, 2020
Consumption of four cups of coffee daily does not impact insulin sensitivity, according to a study published online Dec. 31 in the American Journal of Clinical Nutrition.
First interoperable, automated insulin dosing controller authorised by FDA europeanpharmaceuticalreview
December 25, 2019
The FDA has authorised the first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customise their diabetes management.
CEO urges patients to get Lilly's help paying for insulin fiercepharma
December 20, 2019
After two senators criticized Eli Lilly over access to discounted insulin this week, CEO David Ricks called findings from their report “nonsense."
Arecor Announces Positive Headline Results for Insulin Trial americanpharmaceuticalreview
December 11, 2019
Arecor has announced positive headline results for the Phase I clinical trial of its ultra-rapid acting insulin product candidate, AT247.
Biocon to unlock affordable access to insulins globally biospectrumasia
December 09, 2019
Biocon Biologics, a fully integrated 'pure play' global biosimilars organisation, is taking forward its mission of unlocking affordable access to quality insulins for people with diabetes across the world.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page